Table 4. Factors associated to definite diagnosis in patients with strongyloidiasis in +REDIVI with available extra information (2009–2017).
| Overall (n = 1062) | Definite diagnosis (n = 233) | Probable diagnosis (n = 829) | Univariate analysis (P value) |
Multivariate analysis (OR, 95%CI, and P value) |
|
|---|---|---|---|---|---|
| Mean age at diagnosis, years | 37.9 (SD 13.04, 2–88) | 39.4 (SD 12.7, 2–88) | 37.5 (SD 13.1, 2–82) | 0.058 | OR 1.01 (0.99–1.02), p = 0.181 |
| Gender, male | 520/1062 (49%) | 136/233 (58.4%) | 384/829 (46.3%) | 0.001 | OR 1.69 (1.25–2.29), p = 0.001 |
| Immigrantsa | 699/1062 (65.8%) | 136/233 (58.4%) | 563/829 (67.9%) | 0.007 | OR 0.64 (0.47–0.87), p = 0.006 |
| Time of residence in Spain, years (n = 699)b | 6.4 (SD 5.1, 0–34) | 5.6 (SD 4.3, 0–21) | 6.5 (SD 5.2, 0–34) | 0.050 | - |
| Presence of immunosuppressant condition | 71/1062 (6.7%) | 13/233 (5.6%) | 58/829 (7%) | 0.444 | - |
| HTLV-1 co-infection (n = 224) | 9/224 (4%) | 3/55 (5.5%) | 6/169 (3.6%) | 0.692 | - |
| Presence of eosinophilia (n = 1055) | 867/1055 (82.2%) | 219/232 (94.4%) | 648/823 (78.7%) | <0.001 | OR 3.83 (2.09–7.04), p<0.001 |
| Moderate/Severe eosinophilia (n = 1055) | 377/1055 (35.7%) | 113/232 (48.5%) | 264/823 (32.1%) | <0.001 | OR 1.57 (1.15–2.14), p = 0.004 |
| Presence of symptomsc | 190/1062 (17.9%) | 40/233 (17.2%) | 150/829 (18.1%) | 0.744 | - |
NOTE. Data are reported as number (%) of patients or mean (SD, range).
a Immigrant group compared to VFR-immigrants and travelers.
b Time of residence in Spain in immigrant patients.
c Patients in whom the main reason for consultation were not laboratory test alteration nor health screening.